Prednisolone protein binding in renal transplant patients
- PMID: 3899153
- PMCID: PMC1400673
- DOI: 10.1111/j.1365-2125.1985.tb05050.x
Prednisolone protein binding in renal transplant patients
Abstract
Prednisolone pharmacokinetics and protein binding characteristics were studied in 10 renal transplant patients with various degrees of renal function (serum creatinine: 80-380 mumol/l) who received their usual oral maintenance dose of prednisolone (0.18 +/- 0.04 mg/kg). Plasma was assayed for prednisolone and hydrocortisone by h.p.l.c. and free prednisolone concentrations were determined in each sample by a rapid ultrafiltration technique. Free prednisolone area under curve (AUCu) ranged from 101 to 436 ng ml-1 h and was 6.3 to 15.0% of total prednisolone AUC. The fraction AUCu/AUC was closely related to serum albumin and creatinine concentrations determined at the time of study (multilinear regression correlation coefficient r2 = 0.830, P less than 0.0001); elevated serum creatinine and low albumin concentrations were associated with a higher % free. These results suggest that much of the variability in prednisolone protein binding could be attributed to inter-patient variability in serum albumin and creatinine concentrations. Total prednisolone concentrations would be potentially misleading in any comparisons made between patient groups with different renal function.
Similar articles
-
Endogenous and exogenous glucocorticoids in cushingoid patients.Drug Intell Clin Pharm. 1982 Nov;16(11):863-8. doi: 10.1177/106002808201601109. Drug Intell Clin Pharm. 1982. PMID: 6756849
-
Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.Am J Kidney Dis. 1984 Mar;3(5):339-48. doi: 10.1016/s0272-6386(84)80081-5. Am J Kidney Dis. 1984. PMID: 6702820
-
Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation.Ther Drug Monit. 2001 Jun;23(3):263-7. doi: 10.1097/00007691-200106000-00014. Ther Drug Monit. 2001. PMID: 11360036
-
Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.Cancer Chemother Pharmacol. 2003 Jun;51(6):465-73. doi: 10.1007/s00280-003-0602-3. Epub 2003 Apr 16. Cancer Chemother Pharmacol. 2003. PMID: 12698270 Clinical Trial.
-
The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.Eur J Clin Pharmacol. 1986;30(1):51-5. doi: 10.1007/BF00614195. Eur J Clin Pharmacol. 1986. PMID: 3709632
Cited by
-
Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.Bioanalysis. 2015;7(8):1037-58. doi: 10.4155/bio.15.35. Bioanalysis. 2015. PMID: 25966013 Free PMC article. Review.
-
Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations.Clin Pharmacokinet. 2018 Sep;57(9):1199-1210. doi: 10.1007/s40262-017-0626-1. Clin Pharmacokinet. 2018. PMID: 29330784
-
Evaluation of in vivo efficacy and toxicity of prednisolone-loaded hydrogel-based drug delivery device.Int J Pharm Investig. 2013 Oct;3(4):225-33. doi: 10.4103/2230-973X.121308. Int J Pharm Investig. 2013. PMID: 24350043 Free PMC article.
-
Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.Clin Pharmacokinet. 2012 Nov;51(11):711-41. doi: 10.1007/s40262-012-0007-8. Clin Pharmacokinet. 2012. PMID: 23018468 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical